919
Participants
Start Date
January 31, 2007
Primary Completion Date
September 30, 2007
Study Completion Date
September 30, 2007
tamsulosin hydrochloride
Alphablocker
solifenacin succinate
antimuscarinic
Placebo
Placebo
Linz
Graz
Vienna
Ostrava
Pilsen
Prague
Ústí nad Labem
Aalborg
Frederiksberg
Roskilde
Skejby
Helsinki
Kuopio
Lahti
Oulu
Tampere
Colmar
Cote de Nacre
Créteil
Marseille
Montluçon
Mulhouse
Nîmes
Paris
Ploemeur
Bad Segeberg
Bamberg
Bautzen
Dresden
Eisleben Lutherstadt
Ganderkessee
Hagenow
Halle
Hamburg
Henningsdorf
Hettstedt
Koblenz
Leipzig
München
Münster
Neustadt in Sachsen
Trier
Uetersen
Budapest
Eger
Miskolc
Nyiregyháza
Sopron
Szeged
Szekszárd
Tatabánya
Nijmegen
Maastricht
S'Hertogenbosch
Tilburg
Amsterdam
Apeldoorn
Deventer
Sneek
Utrecht
Fredrikstad
Oslo
Tønsberg
Bialystok
Bydgoszcz
Katowice
Krakow
Lódz
Lublin
Puławy
Szczecin
Warsaw
Amadora-Sintra
Carmo
Coimbra (Covões)
Orta EPE
Pulido Valente
Santa Luzia
Tomar
Moscow
Saint Petersburg
Nitra
Trenčín
Žilina
A Coruña
Barcelona
Madrid
Pontevedra
Seville
Kungälv
Stockholm
Sundsvall
Uddevalla
Uppsala
Reading
Chorley
Cardiff
Swansea
Lead Sponsor
Astellas Pharma Inc
INDUSTRY